Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2009
12/09/2009CN101600725A Preparation of nucleosides ribofuranosyl pyrimidines
12/09/2009CN101597312A Vitamin A acyl cytosine arabinoside conjugate and pharmacome thereof as well as preparation methods and application thereof
12/09/2009CN100567317C Method for modifying nucleoside by medicinal molecules with carboxy or hydroxy
12/08/2009US7629448 Sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide; kits
12/08/2009US7629447 Dideoxynucleoside derivatives
12/08/2009US7629328 Use of 6-oxyamino-7-deazapurine-ribofuranose derivatives, e.g. 1-(6-hydroxylamino-7-ethynyl-7-deazapurin-9-yl)-2-methyl-beta-D-ribofuranose
12/08/2009US7629320 Oxyamino-pyrazolo[3,4-d]pyrimidinylribofuranose derivatives, e.g., 1-(2'-C-methyl- beta -D-ribofuranosyl)-4-methoxylamino-pyrazolo[3,4-d]pyrimidine and 1-(2'-C-methyl- beta -D-ribofuranosyl)-3-cyano-4-methoxylamino-pyrazolo[3,4-d]pyrimidine
12/03/2009WO2009144418A1 Chemical rna synthesis method
12/03/2009US20090299049 Bicyclic Compounds and Their Use
12/03/2009CA2726260A1 Chemical rna synthesis method
12/02/2009EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009EP2125848A1 Antiviral compounds
12/02/2009EP2124986A2 Mycobacterium tuberculosis persistance genes
12/02/2009EP2124555A2 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
12/02/2009CN101591371A Method for preparing gemcitabine or analogues thereof through halogen-exchange fluorination
12/01/2009US7626007 Comprises DNA binding polypeptide for prevention and treatment of oral, arthritic, inflammatory, cancer and infectious diseases
12/01/2009US7625879 Phosphohalohydrins, process for the production thereof and use thereof
12/01/2009US7625877 Acquired Immune Deficiency Syndrome (AIDS); 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine; anti-HIV activity, particularly against a multi-drug-resistant HIV strain; less cytotoxicity, exhibit resistance to inactivation by adenosine deaminase
12/01/2009US7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
12/01/2009US7625871 e.g. 5,6-Dichloro-2-dimethylamino-3-formyl-1-(2,3-O-isopropylidene- beta -D-ribofuranosyl)indole; cytomegalovirus infection, hepatitis B virus infection, herpes simplex virus type 1 infection, varicella zoster virus infection, Epstein Barr virus infection, human herpes virus ;
12/01/2009US7625701 Charge switch nucleotides
12/01/2009CA2303229C Pentopyranosylnucleoside, its preparation and use
11/2009
11/26/2009WO2009143519A2 Biomarkers for myocardial ischemia
11/26/2009WO2009116044A3 Guanine nucleotide derivatives for treating bacterial infections
11/26/2009WO2009074253A3 Clofarabine dietherphospholipid derivatives
11/26/2009CA2724788A1 Hepatoprotectant acetaminophen mutual prodrugs
11/25/2009EP2123653A1 Process for production of crystal of purine nucleoside compound
11/25/2009EP2120565A1 Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
11/25/2009EP1537135B1 Adenosine a3 receptor agonists
11/25/2009CN101589055A Process for the preparation of an (Rp)-8-substituted cAMPS
11/25/2009CN101589044A Process for production of crystal of purine nucleoside compound
11/25/2009CN101585861A N-glycosyl naphthocarbazole compound and synthesis method and application thereof
11/25/2009CN101584672A Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof
11/24/2009US7622279 DNA or RNA comprising self-priming moiety are bound to a solid substrate via 1,3-dipolar azide-alkyne cycloaddition chemistry
11/24/2009CA2418968C Avermectin derivatives
11/24/2009CA2343120C Use of an anthracycline derivative for the treatment of a liver tumor
11/19/2009WO2009139856A1 Vesicles for use in biosensors
11/19/2009WO2009139719A1 Novel synthesis of galactoside inhibitors
11/19/2009WO2009120878A3 Non-natural ribonucleotides, and methods of use thereof
11/19/2009US20090286971 Process for preparing purine nucleosides
11/19/2009US20090286752 Oral formulations of cytidine analogs and methods of use thereof
11/19/2009US20090286284 Method of purifying cytidine diphosphate choline
11/19/2009US20090286247 Novel nucleic acid base pair
11/19/2009CA2724064A1 Novel synthesis of galactoside inhibitors
11/18/2009EP2119722A1 Labelled nucleotides
11/18/2009EP2118117A2 Solid state forms of 5-azacytidine and processes for preparation thereof
11/18/2009EP2118107A1 Mercaptopurine derivatives as anticancer agents
11/18/2009CN101580755A Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris
11/18/2009CN101580529A Didanosine pro-medicament and preparation method thereof
11/18/2009CN101580528A Method for purifying cytidine (deoxidation) and derivatives thereof
11/18/2009CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/18/2009CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/17/2009US7618949 Drug-eluting stents coated with P2Y12 receptor antagonist compound
11/17/2009CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/12/2009WO2009136162A1 Intermediate and processes involved in the preparation of 2 ' -cyano-2 ' -de0xy-n4-palmit0yl-1-beta-arabin0furan0sylcytosine
11/12/2009WO2009136158A1 Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
11/12/2009WO2009135455A2 Method for producing gemcitabine hydrochloride and intermediate products
11/12/2009WO2009098404A3 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
11/12/2009US20090281301 Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate
11/12/2009US20090281300 High-molecular weight derivative of nucleic acid antimetabolite
11/12/2009US20090281299 a ribonucleoside substituted with a phosphonamidite group at the 3'-position, having with serum solubility, cellular distribution and uptake, and stability in vivo
11/12/2009US20090281054 Compositions and methods comprising capuramycin analogues
11/12/2009US20090281052 Indole Antiviral Compositions And Methods
11/12/2009US20090280086 Methods and compositions for treating hepatitis c virus
11/12/2009US20090280059 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/12/2009DE102008023301A1 Neue nukleophile Cytosin-Derivate und ihre Anwendungen New nucleophilic cytosine derivatives and their applications
11/12/2009CA2723702A1 Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
11/11/2009EP2114980A2 Antiviral nucleoside analogs
11/11/2009EP1451203B1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof
11/11/2009CN100558739C Synthesis of protected 3'-amino nucleoside monomers
11/11/2009CN100558411C Tenascin-C nucleic acid ligands
11/10/2009US7615629 Methods and compositions for the tandem synthesis of two or more oligonucleotides on the same solid support
11/10/2009US7615628 Such as 7-(2-thienyl)-3-(2-deoxy- beta -D-ribofuranosyl)-3H-imidazo[4,5-b]pyridine; anticancer agents
11/10/2009US7615619 Triplexes/regulatory sequences for controlling gene expression; antisense agents; nuclease resistance; for detection of particular genes for initiation of amplification; 3'-O-[2-Cyanoethoxy-(diisopropylamino)phosphino]-5'-deoxy-5'-(4-methoxytriphenyl-methylamino)-5-methyl-2'-O,4'-C-methyleneuridine
11/10/2009US7615618 Oligonucleotides comprising a non-phosphate backbone linkage
11/10/2009US7615542 Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
11/10/2009US7615528 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/10/2009CA2278850C The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites
11/10/2009CA2245666C Solid phase synthesis of oligonucleotide n3'.fwdarw.p5' phosphoramidates
11/05/2009WO2009135035A1 Enzymatic determination of potassium ions using stable nad(p)h analogs.
11/05/2009WO2009134469A1 Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use
11/05/2009WO2009133147A1 Novel triazole derivatives, their preparation and their application in therapeutics
11/05/2009WO2009073506A3 Nucleoside prodrugs and uses thereof
11/05/2009US20090274686 Nucleoside phosphonate derivatives
11/05/2009CA2723079A1 Novel triazole derivatives, their preparation and their application in therapeutics
11/04/2009EP2113508A1 Novel triazole nucleoside derivatives, their preparation and their application in therapeutics
11/04/2009EP2112928A1 Synthesis of novel xylosides and potential uses thereof
11/03/2009US7612197 Thermolabile hydroxyl protecting groups and methods of use
11/03/2009US7612187 3-(2-Deoxy- beta -D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purine (1,N6-Etheno-2'-deoxyadenosine, 5) for the determination of the presence or absence of nucleic acids; incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine
11/03/2009US7612184 Polynucleic acid nanomechanical device controlled by hybridization topology
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
10/2009
10/29/2009WO2009132135A1 1' -substituted carba-nucleoside analogs for antiviral treatment
10/29/2009WO2009132123A1 Carba-nucleoside analogs for antiviral treatment
10/29/2009US20090270604 Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine
10/29/2009CA2722177A1 1'-substituted carba-nucleoside analogs for antiviral treatment
10/29/2009CA2722084A1 Carba-nucleoside analogs for antiviral treatment
10/28/2009CN101565441A Dibutyryladenosine cyclophosphate calcium for promoting pig growth and preparation and use thereof
10/28/2009CN101565440A New preparation method of telbivudine
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608602 Beta -1-(4-Allyloxycarbonylamino-2-oxo-1H-pyrimidin-1-yl)-2-deoxy-2,2-difluororibose, for example; for treating or preventing diseases or disorders such as cancer or viral infections
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 201